type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes#181731ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes#184794ClinicalTrials.gov
• The Efficacy of Glucerna SR in Chinese Drug-naïve Subjects With Type 2 Diabetes#201709ClinicalTrials.gov
• Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment#154877ClinicalTrials.gov
• Lifestyle Intervention to Treat Diabetes in the Marshall Islands#172521ClinicalTrials.gov
• GLP-1-mediated Gluco-metabolic Effects of Bile Acid Sequestration#184803ClinicalTrials.gov
• Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial#234369ClinicalTrials.gov
• Dealing With Anxiety: A Cognitive Behavioural Program for Diabetes#234576ClinicalTrials.gov
• The Occurence of Pancreatic Cancer Studied in Association With Newly Diagnosed Diabetes in the Elderly#121266ClinicalTrials.gov
• A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes#154888ClinicalTrials.gov
• The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes#180362ClinicalTrials.gov
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study#7095OpenAlex
• Effect of Lixisenatide on Postprandial Lipid Profile in Obese Type 2 Diabetic Patients#180356ClinicalTrials.gov
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)#28569ClinicalTrials.gov
• Glucose Reduction by Early Acarbose Treatment in Basal Insulin#123403ClinicalTrials.gov
• GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin#126053ClinicalTrials.gov
• Acetylcarnitine and Insulin Sensitivity#143712ClinicalTrials.gov
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination#152351ClinicalTrials.gov
• Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients#160270ClinicalTrials.gov
• IL-1RA, Acute Exercise, and Beta-cell Function#160282ClinicalTrials.gov
• Anti-inflammatory Status in DM2 Treated Patients#201717ClinicalTrials.gov
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy#158154ClinicalTrials.gov
• The Effects of the Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Mini Gastric Bypass on the Remission of Type II Diabetes Mellitus#253142ClinicalTrials.gov
• Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea#136217ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin#180335ClinicalTrials.gov
• A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients#184783ClinicalTrials.gov
• Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin#184793ClinicalTrials.gov
• Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations#175057ClinicalTrials.gov
• Study on Liver Fat Content and Visceral Fat Mass in Overweight and Obese Type 2 Diabetes Patients After Treatment With Basal Insulin#18569ClinicalTrials.gov
• Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease#18805ClinicalTrials.gov
• Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease#28553ClinicalTrials.gov
• A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)#28580ClinicalTrials.gov
• INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control#136248ClinicalTrials.gov
• GIP/GLP-1 Co-Activity in Subjects With Overweight and Type 2 Diabetes: Lowering of Food Intake#136273ClinicalTrials.gov
• A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus#143811ClinicalTrials.gov
• A Titration Study of a Glucagon-Like Peptide-1 (GLP-1) Analogue in Patients With Type 2 Diabetes Treated With Metformin.#146399ClinicalTrials.gov
• Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin#172524ClinicalTrials.gov
• Study Of Safety And Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes (MK-8835-016)#184770ClinicalTrials.gov
• Interventional Study of Active Weight Management in Patients With Type 2 Diabetes and Obesity in Routine Clinical Practice During 12 Months.#234560ClinicalTrials.gov
• Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes#261435ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin#272322ClinicalTrials.gov
• A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin#272324ClinicalTrials.gov
• Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes#127821ClinicalTrials.gov
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin#162419ClinicalTrials.gov
• Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone#226185ClinicalTrials.gov
• Effect of Sitagliptin and Empagliflozin in Combination With Metformin on Hs-CRP Levels in Patients With Type 2 Diabetes Mellitus#238314ClinicalTrials.gov
• Effects of Fatty Acid Delivery on Heart Metabolism and Function in Type 2 Diabetes (T2DM#18538ClinicalTrials.gov
• An Open Study to Evaluate Whether Pack Size Affects Compliance of Metformin Treatment in Subjects With Type II Diabetes#123426ClinicalTrials.gov
• A Study To Evaluate The Safety And Efficacy Of An Investigational Diabetes Drug In Poorly Controlled Type II Diabetics#208358ClinicalTrials.gov
• Evaluation of the Integrated Radio Frequency Denervation System to Improve Glycemic Control in Type 2 Diabetic Subjects#121255ClinicalTrials.gov